- Investing Ideas
- Global Pharmaceuticals & Biotech Spotless Management
Global Pharmaceuticals & Biotech Spotless Management
Results
6
Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.
6 companies
AstraZeneca
Market Cap: UK£214.0b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£137.96
7D
2.7%
1Y
28.1%
Gilead Sciences
Market Cap: US$160.4b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$128.10
7D
-2.3%
1Y
13.4%
Chugai Pharmaceutical
Market Cap: JP¥12.3t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥7,340.00
7D
-3.6%
1Y
-4.1%
Orion Oyj
Market Cap: €9.8b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€69.25
7D
1.7%
1Y
11.2%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥36.2b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.
688578
CN¥80.02
7D
-7.9%
1Y
-15.7%
Xiamen Amoytop Biotech
Market Cap: CN¥23.4b
Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.
688278
CN¥56.68
7D
2.8%
1Y
-23.3%